MMA Schwaller and Associates

Thomas Piquereau

MMA Schwaller and Associates
Insurance contractor

Thomas Piquereau is an Insurance contractor for MMA Schwaller and Associates since October 2022. Before, he was Deputy General Rapporteur of the French Competition Authority from 2016 to 2022. He led the Regulated professions unit created following the tasks entrusted to the Authority by the Macron Act of 6 August 2015. He worked at the Directorate for Competition, Consumer Affairs and Fraud Control (DGCCRF) in Paris, as Deputy head of the Merger Task Force. He graduated from the "Ecole Nationale de la Statistique et de l’Administration Economique" (ENSAE) and from the Paris Dauphine University (Industrial Organisation).

Vidéos

Thomas Piquereau (Autorité de la concurrence), Distribution pharmaceutique : l'avis de l'Autorité de la concurrence, 190403
Thomas Piquereau 11 avril 2019 Paris

Articles

8304 Bulletin

Francis Amand, Thomas Piquereau The French Merger Guidelines 2007

3158

Central Office for Competition, Consumption and Fraud Repression, May 2nd, 2007, Guidelines on concentrations control, Procedure and Analysis Direction générale de la concurrence, de la consommation et de la répression des fraudes (DGCCRF), 2 mai 2007, Lignes directrices relatives au contrôle des (...)

Catherine Boussac, Jennifer Siroteau, Jérôme Vidal, Thomas Piquereau The French Minister of the Economy clarifies its position on the risk of coordination by parent companies while clearing its first transaction in the banking sector (Natixis)

5146

Summary The NatIxis case was the first decision by the French Minister of the Economy on an important merger in the banking sector, which was recently included in his area of responsibility. Examination of the proposed merger provided the occasion to apply a national approach to the banking (...)

15563 Revue

Frédérique Berrod, Luc Besançon, Philippe Besset, François Blanchecotte, Gilles Bonnefond, Céline Devienne, Martial Dubonnet, Luis Godinho, Thomas Piquereau Santé et droit de la concurrence

1927

Cette série d’articles analyse la politique de concurrence française dans le secteur de la santé, notamment l’avis délivré par l’Autorité de la concurrence en avril 2019 sur les secteurs de la distribution du médicament et de la biologie médicale. Chaque article traite le sujet avec une perspective (...)

Livres

Envoyer un message